Zhengye Biotechnology Holding ZYBT Revenue Breakdown

NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT
Annual revenue breakdowns for Zhengye Biotechnology Holding, fiscal 2022 to 2024, as reported in its filings.
Annual history

Zhengye Biotechnology Holding Revenue by Product & Service

Years FY 2022–2024
Lines 3
FY 2024 Total $186.36M

Direct Sales Channel was Zhengye Biotechnology Holding’s largest product and service line in fiscal 2024, bringing in $121.77M of $186.36M (65%).

Zhengye Biotechnology Holding revenue by product and service, fiscal 2022 to 2024
Product and Service FY 2022 FY 2023 FY 2024
Direct Sales Channel $207.32M $159.53M $121.77M
Distribution Network $47.85M $49.62M $59.85M
Government Tender & Procurement $5.10M $2.50M $4.73M
Total $260.27M $211.65M $186.36M

Zhengye Biotechnology Holding revenue by product and service: what the figures show

Zhengye Biotechnology Holding brought in $186.36M from its three product and service lines in fiscal 2024, the year ended December 31, 2024. That was down 12.0% from $211.65M in fiscal 2023. Direct Sales Channel was the largest at $121.77M (65.3%), ahead of Distribution Network at $59.85M (32.1%) and Government Tender & Procurement at $4.73M (2.5%).

Compared with fiscal 2023, Government Tender & Procurement grew fastest, up 89.2% to $4.73M, while Direct Sales Channel fell the most, down 23.7% to $121.77M. From fiscal 2022 to 2024, combined revenue from these lines fell from $260.27M to $186.36M, a compound annual decline of 15.4%. Direct Sales Channel's share of the total fell from 79.7% to 65.3%.

Questions

Zhengye Biotechnology Holding Revenue Breakdown FAQ

How does Zhengye Biotechnology Holding make money?

Zhengye Biotechnology Holding (ZYBT) reports its revenue by product and service. In fiscal 2024, Direct Sales Channel was its largest product and service line, bringing in $121.77M (65.3% of the total), followed by Distribution Network at $59.85M (32.1%).

What is Zhengye Biotechnology Holding's largest product and service line?

Direct Sales Channel was Zhengye Biotechnology Holding's largest product and service line in fiscal 2024, bringing in $121.77M, or 65.3% of the $186.36M total across its three product and service lines.

Which Zhengye Biotechnology Holding product and service line is growing the fastest?

Among Zhengye Biotechnology Holding's product and service lines that make up at least 2% of revenue, Government Tender & Procurement grew fastest in fiscal 2024, up 89.2% from $2.50M to $4.73M.

Where does this revenue breakdown data come from?

Every figure comes from Zhengye Biotechnology Holding's annual financial filings, as reported. Each line keeps the name Zhengye Biotechnology Holding gives it, and years follow its fiscal calendar.

How far back does Zhengye Biotechnology Holding's revenue breakdown go?

Zhengye Biotechnology Holding's revenue by product and service goes back to fiscal 2022, with figures through fiscal 2024. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.